How Big Pharma And Capitalism Create Deadly Antibiotic Resistance Which Could Kill Millions | WHAT REALLY HAPPENED

How Big Pharma And Capitalism Create Deadly Antibiotic Resistance Which Could Kill Millions

A recent meningitis case at Children’s National Hospital raises serious concerns about antibiotic resistance in the common bacterium that caused it, researchers from the hospital wrote in a case report. Their findings, published online August 3 in the Journal of the Pediatric Infectious Disease Society, could change laboratory and clinical practice across the U.S. and potentially around the globe.

Neisseria meningitidis is the leading cause of bacterial meningitis in adolescents and an important cause of disease in younger children as well, say case report authors Gillian Taormina, D.O., a third-year fellow in Pediatric Infectious Diseases at Children’s National, who was on service for this recent case, and Joseph Campos, Ph.D., D(ABMM), FAAM, director of the Microbiology Laboratory and the Infectious Diseases Molecular Diagnostics Laboratory at Children’s National.

As standard clinical practice in the U.S., they explain, patients who are thought to have this infection are typically treated first with the broad-spectrum antibiotic ceftriaxone while they wait for a microbiology lab to identify the causative organism from blood or cerebrospinal fluid samples.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA